Search - tctmd.com

Displaying 361 - 380 of 539

Sort: Relevancy | Date

News Daily News

TAVR Used for Severe Regurgitation Without Stenosis

February 20, 2013

News Daily News

Self-Reported Financial Conflicts Have No Effect on Cardiovascular Trial Outcomes

Caitlin E. Cox

February 07, 2013

News Daily News

IMS III: Endovascular Therapy Fails to Improve Stroke Recovery vs. t-PA Alone

Jason Kahn

February 07, 2013

News Daily News

PROTECT AF: Longer Follow-up Provides Clarity on Watchman vs. Warfarin for A-fib

Caitlin E. Cox

January 30, 2013

News Daily News

ESC Report Recommends Radial Access as Default Approach for PCI

January 30, 2013

News Industry News

Direct Flow Medical® Receives CE Mark for Transcatheter Aortic Heart Valve System That Virtually Eliminates Aortic Regurgitation

January 27, 2013

News Daily News

Snare Device for LAA Closure Safe, Effective in Small A-fib Study

L.A. McKeown

January 16, 2013

News Daily News

Registro Europeo: Los Dispositivos TAVR revelan Resultados Similares a Corto y Largo Plazo

Caitlin E. Cox

January 16, 2013

News Daily News

European Registry: TAVR Devices Show Similar Short-, Long-term Outcomes

Caitlin E. Cox

January 16, 2013

News Daily News

Year in Review: Physicians Highlight the Most Important Interventional News of 2012

Caitlin E. Cox

January 02, 2013

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2012

Jason Kahn

January 02, 2013

News Industry News

Abbott Announces FDA Approval and U.S. Launch of Next-Generation XIENCE Xpedition™ Drug Eluting Stent System

January 02, 2013

News Daily News

EES Outperform First-Generation DES in Treatment of CTOs

L.A. McKeown

December 27, 2012

News Daily News

Real-World Equivalence Seen for Zotarolimus- and Everolimus-Eluting Stents

Caitlin E. Cox

December 26, 2012

News Daily News

‘Top Ten’ Advances of 2012 Highlighted by AHA-ASA, ACC

Caitlin E. Cox

December 26, 2012

News Daily News

BCIS-1 Published: Elective IABP Benefits High-Risk PCI Patients

Caitlin E. Cox

December 12, 2012

News Daily News

Study Explores Endovascular Treatment for Ascending Aortic Dissection

Caitlin E. Cox

November 14, 2012

News Daily News

Percutaneous Device-Based Closure Successful in Children with Ventricular Septal Defects

L.A. McKeown

November 14, 2012

News Conference News TCT 2012

TVT Registry Sparks Discussion on Device Evaluation, Treatment Comparisons

October 26, 2012

News Industry News

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

October 25, 2012

Advertisement

TAVR Used for Severe Regurgitation Without Stenosis

Self-Reported Financial Conflicts Have No Effect on Cardiovascular Trial Outcomes

IMS III: Endovascular Therapy Fails to Improve Stroke Recovery vs. t-PA Alone

PROTECT AF: Longer Follow-up Provides Clarity on Watchman vs. Warfarin for A-fib

ESC Report Recommends Radial Access as Default Approach for PCI

Direct Flow Medical® Receives CE Mark for Transcatheter Aortic Heart Valve System That Virtually Eliminates Aortic Regurgitation

Snare Device for LAA Closure Safe, Effective in Small A-fib Study

Registro Europeo: Los Dispositivos TAVR revelan Resultados Similares a Corto y Largo Plazo

European Registry: TAVR Devices Show Similar Short-, Long-term Outcomes

Year in Review: Physicians Highlight the Most Important Interventional News of 2012

TCTMD’s Top 10 Most Popular News Stories for 2012

Abbott Announces FDA Approval and U.S. Launch of Next-Generation XIENCE Xpedition™ Drug Eluting Stent System

EES Outperform First-Generation DES in Treatment of CTOs

Real-World Equivalence Seen for Zotarolimus- and Everolimus-Eluting Stents

‘Top Ten’ Advances of 2012 Highlighted by AHA-ASA, ACC

BCIS-1 Published: Elective IABP Benefits High-Risk PCI Patients

Study Explores Endovascular Treatment for Ascending Aortic Dissection

Percutaneous Device-Based Closure Successful in Children with Ventricular Septal Defects

TVT Registry Sparks Discussion on Device Evaluation, Treatment Comparisons

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content